PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
21-Feb-2020 Exclusive Interview with Martin Everett, CSO, Antabio, ahead of the Superbugs & Superdrugs Conference SMi Group
21-Feb-2020 Thousands of patients to benefit from new way to pick up prescriptions at Boots UK Boots UK
21-Feb-2020 First Patient Dosed with Transgene’s Oncolytic Virus TG6002, Administered by Intrahepatic Artery Infusion in Colorectal Cancer with Liver Metastases Transgene
21-Feb-2020 Statement regarding Major Holdings NMC HEALTH PLC
20-Feb-2020 Vifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron portfolio Vifor Pharma Group
20-Feb-2020 Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline Polyphor
20-Feb-2020 Montis Biosciences launched with €8,4 million seed financing and a novel approach to immuno-oncology Montis Biosciences
20-Feb-2020 IDT launches xGen Prism DNA Library Prep Kit Integrated DNA Technologies, Inc.
20-Feb-2020 Medigene AG: Medigene participates at upcoming conferences Medigene AG
19-Feb-2020 Pfizer’s Vyndaqel set to achieve blockbuster status in 2021 with new EU approval for expanded use in ATTR-CM Pfizer
19-Feb-2020 Driven by its successful debut, the Second Annual International HealthTech Innovation Days will take place in Paris on June 22nd & 23rd France Biotech
19-Feb-2020 Lundbeck increases its share capital by 11,497 shares (0.0058 % of outstanding shares) as a result of exercise of employee warrants Lundbeck
19-Feb-2020 Orgenesis announces collaboration with the John Hopkins University for the development and processing of cell and gene based clinical therapeutics Orgenesis
19-Feb-2020 Immutep reports positive TACTI-002 data Immutep
19-Feb-2020 European Commission Grants Marketing Authorisation for VYNDAQEL®  (tafamidis), the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Pfizer
19-Feb-2020 SEARCHING FOR BIOMARKERS AND THERPEUTIC AGENTS AGAINST BREAST CANCER Karl Landsteiner University
18-Feb-2020 Director resignation - H.J. Mark Tompkins NMC HEALTH PLC
18-Feb-2020 Director resignation - Mr Abdulrahman Basaddiq NMC HEALTH PLC
18-Feb-2020 Director resignation - Hani Buttikhi NMC HEALTH PLC
18-Feb-2020 New company takes aim at treatments for multiple sclerosis Pheno Therapeutics